Category: antibody cocktail

  • Regeneron’s COVID-19 antibody cocktail gets US emergency licence

    Regeneron’s antibody cocktail is the latest COVID-19 drug to receive Emergency Use Authorization in the US, becoming the first therapy of this kind to become available. The cocktail of casirivimab and imdevimab is still being investigated in trials but the FDA has enough data to grant a temporary licence while the pandemic continues. Formerly known […]